WO2016130983A1

WO2016130983A1 - Probiotic deodorant

Info

Publication number: WO2016130983A1
Application number: PCT/US2016/017856
Authority: WO
Inventors: Kenneth Davin FINE
Original assignee: Fine Kenneth Davin
Priority date: 2015-02-12
Filing date: 2016-02-12
Publication date: 2016-08-18

Abstract

In various implementations, a deodorant may include probiotics. The deodorant may be nonmetallic. The deodorant may include a substrate and the probiotics may be applied to the substrate. A user may apply the deodorant to the user's skin to reduce odor. probiotic deodorant

Description

PROBIOTIC DEODORANT

CROSS-REFERENCE TO RELATED APPLICATION

[001] This application claims the benefit of U.S. Provisional Patent Application No. 62/115,334, entitled "PROBIOTIC DEODORANT," filed on February 12, 2015, which is hereby incorporated by reference for all purposes.

TECHNICAL FIELD

[002] The present invention relates to deodorants. BACKGROUND

[003] Body odor is commonly caused in humans when naturally occurring perspiration is processed (e.g., fermented) by bacteria present on the skin. People mostly use commercially available deodorants containing aluminum, titanium, magnesium, and/or zirconium to combat body odor. However, today, in a growing toxin-conscious populace, many people are concerned about the application of aluminum, titanium, or zirconium on the skin because absorption of compounds containing these metallic elements through the skin into the body might contribute to heavy metal toxicity. Furthermore, standard deodorants only attempt to adsorb odiferous compounds with the metallic elements and/or mask the odor with added perfumes but they do not address the problem of body odor at its cause.

SUMMARY

[004] In various implementations, a deodorant may be provided that includes probiotics. The probiotics may be dried and/or live. The deodorant may include a substrate and the probiotics may be disposed on the substrate. The deodorant may be at least partially hydrated prior to applying the deodorant on the skin of a user (e.g., when dried probiotics are utilized in the deodorant). In some implementations, the deodorant may be nonmetallic.

[005] In various implementations, a deodorant may be provided to be applied to an external surface of a user (e.g., human). The deodorant may include a substrate and one or more probiotics disposed on the substrate. The probiotics may not ferment perspiration (e.g., from a human).

[006] Implementations may include one or more of the following features. The deodorant may be nonmetallic. The deodorant may include less than a predetermined amount of metallic ingredients (e.g., less than approximately 20%, less than

approximately 10%, and/or less than approximately 5% by weight). In some

implementations, at least one of the probiotics may be live or dormant (e.g., freeze dried, dried, etc.). One or more of the probiotics may be naturally present in a human (e.g., in the gastrointestinal tract). One or more of the probiotics included in the deodorant may include Lactobacillus and/or non-pathogenic Streptococci. One or more of the probiotics may not produce one or more predetermined odor causing compounds in a level greater than a predetermined level (e.g., approximately 10% by weight of the total compounds produced by the one or more probiotics). The application of the deodorant to an external surface of the skin may reduce the magnitude of one or more pathenogenic bacteria on the external surface of the skin (e.g., when compared to the amount of pathenogenic bacteria present on the surface of the skin of a user prior to application). In some implementations, one or more additional compounds may be disposed on the substrate. For example, an additional compound may include a fragrance. In some

implementations, the deodorant may not include fat, protein, and/or carbohydrate. The substrate may be a pad (e.g., woven, polymer, plastic, etc.).

[007] In various implementations, a deodorant may include a container and one or more probiotics disposed in the container. One or more of the probiotics may not ferment perspiration (e.g., perspiration present on an external surface of a user). The deodorant may include an applicator. The applicator may be used to apply the deodorant on an external surface of a user (e.g., human).

[008] Implementations may include one or more of the following features. The deodorant may be nonmetallic. One or more of the probiotics included in the probiotic may be live and/or dormant (e.g., dried). In some implementations, one or more of the dormant probiotics (e.g., dried probiotics) may be revived using a hydrating agent. The deodorant may include a hydrating agent that is capable of reviving one or more of the probiotics in the deodorant. The applicator may include a brush. The applicator may include a rotatable member. For example, during application of the deodorant, an exterior surface of the rotatable member may contact one or more of the probiotics in the container, and at least temporarily adhere to the rotatable member. As the rotatable member rotates away from a portion of the container in which the one or more probiotics are disposed, one or more probiotics may be positioned to allow application of the adhering probiotic(s) an external area of a human.

[009] In various implementations, applying a deodorant may include obtaining a substrate with one or more probiotics disposed on the substrate, and applying one or more of the probiotics to an external area of a user (e.g., human) by contacting the substrate with the external area. A hydrating agent may be applied to the substrate to revive one or more of the probiotics. One or more of the probiotics may not ferment perspiration (e.g., present on the external are of a user.

[010] Implementations may include one or more of the following features. In some implementations, a hydration agent may be applied to a substrate of the deodorant to at least partially hydrate the substrate, and one or more of the probiotics may be applied to the substrate from a container in which the one or more probiotics is housed. Applying one or more of the probiotics to the at least partially hydrated substrate may revive one or more of the probiotics applied to the substrate. In some implementations, a substrate may be obtained that includes one or more of the probiotics disposed on the substrate, and applying a hydrating agent to the substrate may revive at least a portion of the probiotics disposed on the substrate. The substrate may include an applicator. In some

implementations, obtaining a substrate with one or more probiotics includes applying a hydrating agent to the applicator to at least partially hydrate the applicator; and dipping the applicator in a container to allow one or more probiotics to transfer from the container to the applicator. The container may houses one or more of the probiotics, and at least a portion of the probiotics may transfer to the applicator when the applicator is dipped in the container. At least a portion of the probiotics transferred to the applicator may be hydrated by the hydrating agent on the applicator. In some implementations, contacting the substrate with the external area (e.g., during application of the deodorant) exfoliates at least a portion of the skin in the external area. The substrate may includes a first layer and at least one additional layer, in some implementations. During use, at least the first layer of the substrate may be removed to allow at least a portion of the probiotics on at least one of the additional layers substrate to be exposed and/or transferred to the external area by contacting one or more of the additional layers of the substrate with an external area of the user.

[Oil] The details of one or more implementations are set forth in the accompanying drawings and the description below. Other features, objects, and advantages of the implementations will be apparent from the description and drawings.

BRIEF DESCRIPTION OF THE DRAWINGS

[012] For a more complete understanding of this disclosure and its features, reference is now made to the following description, taken in conjunction with the accompanying drawings, in which:

[013] Figure 1 illustrates an implementation of an example deodorant pad. [014] Figure 2 illustrates an implementation of an example deodorant pad. [015] Figure 3 illustrates an implementation of an example deodorant. [016] Like reference symbols in the various drawings indicate like elements. DETAILED DESCRIPTION

[017] In various implementations, a deodorant may be utilized by a user to inhibit body odor. The deodorant may be self-applied by an individual. The deodorant may include probiotics. For example, the probiotics in the deodorant may include live or dormant healthful bacteria that when present in internal body cavities of the body (e.g., intestinal tract, oral cavity, and/or vagina) have been proven to overcome the growth of less healthful bacteria (e.g., anaerobic bacteria). Since the type of bacteria that metabolize sweat gland secretions into odiferous aromatic compounds are the same or similar types of less healthful bacteria, the application of a probiotic deodorant may inhibit odor by allowing one of more of the bacteria of the probiotic bacteria to overcome the growth of the less healthful bacteria.

[018] In some implementations, the deodorant may be utilized to minimize skin conditions of a user. For example, some skin conditions may be caused and/or exacerbated by the presence of yeast on the skin. The yeast may grow in the absence of bacteria. Thus, application of a probiotic deodorant may encourage probiotic growth and inhibit (e.g., by overcoming) yeast growth. For example, symptoms of seborrheic dermatitis and/or rosacea may be inhibited by use of the probiotic deodorant since the probiotic deodorant may inhibit yeast growth or other undesirable micro-organisms, including bacteria. In some implementations, the application of probiotics may overcome the presence of pathogenic bacteria such as, Staphylococcus aureus on the skin, which may colonize and/or potentially super-infect chronically inflamed and/or disrupted skin (e.g., as seen in eczema and/or other chronic inflammatory skin disorders). In some implementations, application of probiotic deodorant may allow a user to avoid the use of more typical applications of antibiotics via soaps and/or lotions; and thus, the vicious cycle of antibiotic -recolonization may be disrupted that may induce antibiotic resistance in such organisms.

[019] In some implementations, the deodorant may be nonmetallic. A nonmetallic deodorant may not include metals, such as alkaline metals, alkaline earth metals, transition metals, basic metals, and/or metalloids (e.g., semimetals). For example, a deodorant may not include Aluminum, Titanium, and/or Zirconium. In some

implementations, a nonmetallic deodorant may include less than 10% by weight of a metal compound. In some implementations, the deodorant may not include a compound that inhibits bacteria growth, such as an antibiotic (e.g., Triclosan). User satisfaction may increase by providing a deodorant that is nonmetallic and/or does not include an antibacterial (e.g., since some users may have concerns about absorption of metals and/or anti-bacterials via skin application).

[020] The deodorant includes one or more probiotics. The probiotics may promote the growth of bacteria on the skin that does not ferment perspiration, in some

implementations. For example, by applying the deodorant to an area of skin, the user may deposit at least a portion of the probiotics from the deodorant onto the skin. The probiotics deposited on the skin may grow (e.g., binary fission). As the probiotics on the area of skin grow, other bacteria present in the area may be exist in lower magnitudes and/or die (e.g., the colony may enter the death phase). When the previously existing bacteria are in lower magnitudes and/or die, body odor (e.g., produced by the processing of perspiration by existing odor-generating bacteria) may be reduced (e.g., when compared with body odor without application of the deodorant).

[021] In some implementations, the probiotics utilized in the deodorant may be selected from a group of bacteria based on odor inhibiting criteria. For example, the bacteria selected may not ferment perspiration. The bacteria selected may not produce common predetermined odor causing compounds in high levels (e.g., greater than 20% by weight). For example, bacteria that do not produce high levels (e.g., greater than 20% by weight) of propanoic acid when processing and/or in the presence of perspiration may be selected for inclusion in the probiotic. In some implementations, bacteria that do not produce high levels (e.g., greater than 20%) of 3-methylbutanoic acid when processing and/or in the presence of perspiration may be selected for inclusion in the probiotic.

[022] In various implementations, the probiotic may include one or more predetermined strains of bacteria (e.g. Lactobacillus species, non-pathogenic Streptococci). . In some implementations, the organisms (e.g., bacteria) in the probiotic may be live, dried, and/or combinations thereof. The organisms in the probiotic may be similar or identical to one or more of the bacteria used in intestinal probiotic preparations, such as the previously mentioned Lactobacillus and Streptococci species. In some implementations, the organism(s) selected for inclusion in the probiotic deodorant may be selected to be similar to that of a healthy skin bacterial flora.

[023] In some implementations, at least a portion of the probiotic may be dried (e.g., freeze dried). For example, the dried probiotic may include dried bacteria. The dried bacteria may include dormant or inert bacteria. By utilizing dried probiotics, the shelf life of the deodorant may be increased (e.g., when compared to deodorant with live probiotic). When the probiotics are utilized in live form in a deodorant, the number of probiotic organisms may decrease overtime (e.g., due to reduction in nutrients available or other reason for entry into a death phase of a colony of organisms). Thus, by utilizing dried probiotics (e.g., bacteria), the number of probiotic organisms (e.g., bacteria) in the deodorant may be maintained at a higher level over time than when utilizing live probiotics.

[024] When the dried probiotic is activated (e.g., revived), the probiotic may become live probiotic. For example, when dried bacteria in a dried probiotic are activated, at least a portion of the dried bacteria may be revived (e.g., return to a live state).

[025] In some implementations, other compounds may be included in the deodorant. For example, natural and/or artificial fragrances may be included in the deodorant. The fragrance(s) may transfer to the user upon application of the deodorant to a user, in some implementations. The other compounds included in the deodorant may not substantially inhibit growth of the probiotic in the deodorant. In some implementations, the other compounds may not include fat(s), protein(s), and/or carbohydrate(s) to inhibit the deodorant from turning rancid. In some implementations, the other compounds may not include a percentage by weight of fat(s), protein(s), and/or carbohydrate(s) greater than 5% of total deodorant weight to inhibit the deodorant from turning rancid.

[026] In various implementations, a deodorant may include a substrate, and the probiotic may be disposed on the substrate. Figure 1 illustrates an implementation of an example deodorant. As illustrated, the deodorant 100 includes a substrate 110 and probiotic disposed on the substrate 120.

[027] The substrate may include any appropriate substrate. For example, the substrate may include a woven material (e.g., cotton, hemp, polyester, and/or any other appropriate material). In some implementations, the substrate may include a pad (e.g., foam pad, cotton pad, polymer gel pad, cellulose pad, etc.) The substrate may include one or more layers. Each layers of the pad, in multilayered pads, may be similar to different. The substrate may include a container and applicator. In some implementations, the container and applicator may be integrated (e.g., a roll-on applicator, a spray on applicator, etc.)

[028] The substrate may be any appropriate shape. For example, the substrate may have a square, oval, rectangular, square, regular polygon, or irregular polygon shape. In some implementations, the substrate may include a cotton round.

[029] The substrate selected for the deodorant may be based on the method of application of the deodorant on the user's skin. The probiotic may be applied to the substrate in a variety of appropriate ways. For example, the substrate may include a member onto which the probiotic may be manually or automatically applied.

[030] In some implementations, the substrate may include a roll-on bottle. In a roll on bottle, the probiotic and/or a container to house the probiotic may be integrated into the housing of the substrate. For example, the substrate may be included in a container in which the probiotic is disposed (e.g., live and/or dried). The substrate may include a rotatable member (e.g., ball and/or cylinder coupled to a housing) disposed above the container such that an exterior surface of the rotatable member contacts the probiotic in the container, at least a portion of the probiotic in the container at least temporarily adheres to the rotatable member, and then the rotatable member rotates away from the a ball to allow application of probiotic on a user's skin. In some implementations, the substrate may include two containers (e.g., within the housing of the substrate). A first container may house a hydrating agent (e.g., water) and the second container may include the probiotic and/or other compounds. During use, at least a portion of the hydrating member in the first container may adhere to, be absorbed by, and/or otherwise couple to an exterior surface of the rotatable member. The hydrated surface of the rotatable member may then rotate to contact the probiotic in the second container such that at least a portion of the probiotic in the second container may adhere to the hydrated surface. This hydrated surface of the rotatable member may then rotate further to allow the user to apply the probiotic from the hydrated surface at least partially onto the user's skin.

[031] In some implementations, the substrate may include a pad, such as a cotton pad (e.g., round, oval, rectangular, irregular, and/or any other appropriate shape). The probiotic may be applied to the pad in a variety of ways. In some implementations, the probiotic may be applied to the substrate by dipping the substrate in a container of probiotic (e.g., dried or live). The probiotic may be applied to the substrate by pouring and/or sprinkling dried probiotic on the substrate. The probiotic may be applied to the substrate by brushing the substrate with probiotic.

[032] In some implementations, a hydrating agent may be utilized to facilitate adherence of the probiotic on the substrate. For example, a hydrating agent may be applied to the substrate (e.g., sprinkled onto a pad, a pad may be moistened by placing the pad under a faucet of running water, etc.), and then probiotic may be applied to the substrate. Applying the hydrating agent may revive organism in the probiotic, in some implementations. By decreasing the amount of time between hydrating a dry probiotic and applying the probiotic to an area of the body, the amount of live probiotic applied to the body may be increased, in some implementations.

[033] The probiotic of the deodorant may be included in a probiotic container separate from the substrate. For example, probiotic for the deodorant may be disposed in a container such as a shaker, a jar, a tube, and/or a capsule. The container may facilitate the application of the probiotic onto the substrate, in some implementations. For example, the container may include a perforated or mesh lid through which probiotics in the container may be shaken or poured out of the container. The container may include a wide mouth that allows an applicator (e.g., brush, spatula, spoon, sponge, foam, and/or any other appropriate applicator) and/or the substrate to be dipped into the container to contact the probiotics in the container. In some, implementations, the substrate may include a multi -barrel (e.g., more than one barrel) container, such as a dual barrel syringe. For example, a first probiotic (e.g., one or more types of probiotic organisms) may be disposed in a first barrel, and a hydrating agent may be disposed in a second barrel. The outlet of each barrel may feed into the container outlet such that a portion of the first probiotic and a portion of a hydrating agent may exit the container outlet concurrently. For example, the substrate may include container with wall(s) to separate components (e.g., hydrating agent and/or probiotic), an application area (e.g., that contacts the external surface of a user to allow transfer), and an actuator to allow a user to move the components from inside the container to the application area. For example, the actuator may include a piston that pushes component(s) to the application area, and an actuating member (e.g., dial, button, etc.) to engage with the piston and allow the user to actuate the piston. The application area may include openings that allow the components (e.g., hydrating agent and/or probiotics) to move from the inside of the container to the outside of the container to allow application to an external surface of a user. In some

implementations, one or more additional barrels may be included in the container such that the contents of the additional barrels (e.g., second probiotic(s), additional hydrating agents, other compounds such as fragrances, etc.) may exit the container outlet concurrently with the contents of the first barrel and the second barrel. [034] In some implementations, the probiotic may be applied to the substrate and coupled to the substrate. For example, the substrate may be capable of retaining at least a portion of the probiotic applied to the substrate. The substrate may include a structure (e.g., fibers that adhere probiotics, frictional retention, and/or other appropriate structural features) that allows at least a portion of probiotics that contact the substrate to be retained (e.g., at least temporarily) by the substrate. The substrate may include a bonding agent (e.g., polymer gel) that adheres at least a portion of the probiotic that contacts the substrate and/or that retains at least a portion of the probiotic applied to the substrate. The bonding agent may allow the probiotic to be transferred to a user's skin during application (e.g., by being water soluble, by having weak bonding properties that allow transfer to the skin when applied with pressure, such as wiping across a surface, etc.). In some implementations, the probiotic may be applied by impregnating the substrate with the probiotic.

[035] In some implementations, the deodorant may include dried probiotic disposed on the substrate. Prior to applying the deodorant to an area of skin, the probiotic and/or substrate may be at least partially hydrated. After the substrate and/or probiotic are at least partially hydrated, the probiotic may be applied to an area of the body (e.g., by wiping the substrate on the area of the body). At least partially hydrating the substrate may hydrate at least a portion of the probiotic and/or revive at least a portion of the probiotic. For example, water may be applied to the substrate (e.g., the substrate may be at least partially submerged in water and/or water may be sprinkled, spritzed, and/or poured on the substrate) and/or probiotic. Since the dried probiotic is inactive, by hydrating the substrate and/or probiotic, at least a portion of the dried probiotic may be activated. Thus, when the probiotic is applied to the area of the body, at least a portion of the probiotic transferred to the area (e.g., the skin) may be revived, live, and/or in the process of being revived. The live organisms in the probiotic may then continue to grow. As the probiotic organisms grow on the area of application, probiotic organisms may overcome the growth of other less healthful organism (e.g., yeast and/or odor causing bacteria). This may inhibit odor from the processing of sweat by certain organisms and/or reduce skin conditions exacerbated by yeast. [036] In some implementations, the substrate may be at least partially hydrated (e.g., at least partially with water) prior to applying the probiotic to the substrate. For example, the substrate may be at least partially hydrated and then probiotic may be disposed (e.g., sprinkling, pouring, and/or otherwise applying) onto to the substrate. In some

implementations, the substrate may be hydrated and then dipped into probiotic (e.g., disposed in a container).

[037] In some implementations, the deodorant may include a layered substrate. Figure 2 illustrates an implementation of an example deodorant 200. The deodorant 200 may include a substrate that includes more than one layer. As illustrated, the deodorant 200 includes a first layer 210 and a second layer 220. The probiotics 230 in the deodorant 200 may be disposed between the first layer 210 and the second layer 220. The probiotics 230 may be coupled to at least one of the first layer 210 and/or the second layer 220, retained between the first layer and the second layer, and/or coupled to a film that is layered between the first layer and the second layer, for example. In some implementations, the layers may be coupled together (e.g., frictionally coupled, at least partially woven together, stitched together, affixed together). In some implementations, portion(s) of the layers of the substrate may be coupled together and other portion(s) may not be coupled together. For example, the edges of the layers may be coupled together and at least a portion of the area inside the perimeter of the substrate may be uncoupled.

[038] In some implementations, at least one of the layers may include a porous material, such as a woven material, paper (e.g., filter paper), plastics (e.g., mesh), and/or any other appropriate material. The layers may have a predetermined texture. For example, the texture of at least one of the layers of the substrate may at least partially exfoliate a portion of the skin to which the deodorant is applied. In some implementations, the texture of at least one of the layers of the substrate may promote use of the deodorant (e.g., soft texture). [039] In some implementations, prior to applying the deodorant to a user's skin, the user may remove at least one layer of the substrate to at least partially expose the probiotics (e.g., to allow the probiotics to be applied to the skin). For example, the probiotics may include live probiotics and, once exposed to air by removal of at least one layer of the substrate, may be applied to the user's skin. By utilizing a removable layer of substrate, the life of the probiotic (e.g., live and/or dried) may be extended (e.g., when compared to a deodorant in which probiotics are disposed on an exterior surface) since exposure to air and/or sunlight may be inhibited.

[040] In some implementations, the probiotics may include dried probiotics. Prior to application of the deodorant to a user's skin, a user may remove at least one layer of the substrate and at least partially hydrate the substrate and/or probiotic. In some

implementations, the user may at least partially hydrate the substrate and/or probiotic (e.g., to revive the probiotic) prior to removing at least one of the layers of the substrate.

[041] In some implementations, the probiotic may be at least partially coupled to the substrate and/or layer(s) of the substrate. For example, the probiotic may be coupled via a water soluble bonding agent (e.g., water soluble polymer), which does not substantially inhibit reviving dried probiotic, to at least one layer of the substrate. In some

implementations, the probiotics may be coupled to a water soluble film, which is capable of coupling the probiotics to the film. The film may be disposed between layers of substrate, coupled to an exterior surface of a layer of the substrate, and/or coupled to an exterior surface of a substrate.

[042] The bonding agent may couple the probiotic (e.g., to the layer and/or film) and allow the probiotics to be released from the bonding agent during application of the deodorant. For example, the bonding agent may release from the substrate and/or the probiotic may be released from the bonding agent when a user applies the deodorant to the user's skin (e.g., by wiping the substrate against the area of application, by patting the substrate against the area of application, and/or any other appropriate application method). [043] The described process may be implemented by various implementations of deodorants, as described. In addition, various operations of the processes may be added, deleted, and/or modified. In some implementations, operation(s) of a process may be performed in combination with operations of other processes. In addition, the order of operation may be altered as appropriate. For example, a substrate may be at least partially hydrated before and/or after application of a probiotic on the substrate. In some implementations, the body of the user may be moistened (additionally moistened and/or already moistened, such as after a shower) and the substrate and/or probiotic may not be hydrated. Rather, the probiotic may be revived with the moisture on the surface of the user's skin, in some implementations.

[044] In some implementations, the probiotic deodorant may include a roll-on container. Figure 3 illustrates an implementation of an example probiotic deodorant 300 that includes a roll-on container. As illustrated, the probiotic deodorant includes a container 310 with at least two separate portions, a first portion 315 and a second portion 318. The first portion 315 may include one or more probiotics 330 and the second portion may include a hydrating agent 340. The container may include a rolling member 320 coupled to allow the rolling member to rotate.

[045] During use, the rolling member may rotate and contact the hydrating agent in the first portion. At least a portion of the hydrating agent may transfer to the rolling member and/or hydrate at least a portion of the rolling member. For example, the rolling member may be porous and absorb at least a portion of the hydrating agent. In some

implementations, the rolling member may not be porous. The rolling member may then further rotate to contact probiotics in the first portion of the container. At least a portion of the probiotics may transfer to the rolling member and at least temporarily adhere to the rolling member (e.g., via the hydrating agent). In some implementations, at least a portion of the probiotics may be dormant and contact with the hydrating agent on the rolling member and/or the hydrated rolling member may revive at least a portion of the probiotics on the rolling member. The rolling member may be further rotated to allow application of the probiotic on an external surface of the user. For example, the rolling member may further rotate to allow transfer of (e.g., expose) the probiotics on the rolling member to an external surface of a user by contacting the rolling member with an external surface of the user. A user may apply the deodorant by rolling the rolling member on an external surface of the user (e.g., skin) and by rolling the rolling member, hydrating agent and/or probiotics are transferred to the rolling member and/or external surface of the user.

[046] In some implementations, the rolling member may be coupled to allow rolling in one or more directions and inhibit rolling in one or more other directions. For example, by allowing the rolling member to be inhibited from rolling in one or more other directions, the rolling member may be coupled to move to contact the contents in the second portion 318 (e.g., hydrating agent 340) prior to contacting the contents of the first portion 315 (e.g., one or more probiotics 330). In some implementations, this may cause the rolling member to contact the hydrating agent prior to the probiotic(s) to ensure that at least a portion of the probiotic(s) are transferred to the rolling member (e.g., since the wetness from the hydrating agent may cause probiotic(s) to at least temporarily adhere to the rolling member). In some implementations, the container may include a barrier (e.g., a protrusion that contacts the rolling member (e.g., to scrape the rolling member) that inhibits probiotics disposed on a surface of the rolling member from entering the second portion of the container and contacting the hydrating agent (e.g., to promote shelf-life, decrease fouling of the rolling member and/or hydrating agent, etc.). For example, a barrier may be disposed proximate a top of the container proximate where the rolling member is coupled to the container and/or may be disposed on a wall separating the first portion and the second portion of the container.

[047] In some implementations, the container may include a single portion in which the hydrating agent and the probiotics are disposed. For example, the hydrating agent and the probiotic may be mixed (e.g., to form a suspension). In some implementations, a binder (e.g., inert gel and/or liquid) may be mixed with the probiotic instead of or in addition to a hydrating agent to facilitate transfer of the probiotic in the container to the rolling member.

[048] In some implementations, the container may be shaken and/or otherwise agitated to promote adherence of the probiotic on the rolling member. In some implementations, the rolling member may be allowed to rotate to allow hydrating agent to be transferred to the rolling member and then the container may be shaken to allow probiotics to be transferred from the first portion to a portion of the rolling member. The rolling member may be further rotated to allow application of the probtiotic on an external surface of the user.

[049] In some implementations, the probiotic deodorant may have a substrate that allows a solid bar to be formed to include probiotic. For example, a bar of probiotic deodorant may be formed with a substrate (e.g., inert immobilization agent that could include, but would not be limited to, low moisture glycerin-like compounds or long chain fatty acid soaps with a very low moisture content, etc.) and probiotic interspersed throughout the bar. To utilize the probiotic bar, the user may apply water to the probiotic bar and then apply (e.g., rub and/or wipe) the probiotic bar against the user's skin and/or wash with the probiotic soap in usual fashion during bathing. In some implementations, the user may apply water to the application area on the user's skin and/or have a premoistened application area (e.g., post-shower skin) and the probiotic bar may be applied to the user's skin.

[050] In some implementations, the probiotic deodorant may be combined with other personal grooming products, such as shampoos, hair conditioners, leave-in hair conditioners, skin lotions, and soap, in either liquid or solid bar form.

[051] In various implementations, the deodorant may be enclosed. Enclosing the deodorant may inhibit sunlight, moisture, and/or air exposure for the probiotic and/or increase the life of the probiotic (e.g., decrease the number of dead probiotic organisms prior to use when compared with unenclosed probiotic deodorants). In some

implementations, the deodorant may include a pad that is enclosed in a package. The package may be removable (e.g., by tearing, cutting, and/or otherwise breaking). The deodorant may be enclosed by a removable package. For example, a solid probiotic bar may be disposed in a removable package, such as a box with a removable lid. As another example, several deodorant pads may be disposed in a removable package such as a container with a removable lid.

[052] In some implementations, to increase shelf-life and/or to increase the amount of live bacteria that may be applied to an area of the body, a probiotic deodorant may be stored in a predetermined temperature range (e.g., in a refrigerator or chiller). In some implementations, the probiotic deodorant may be shelf stable at room temperature in predetermined temperatures (e.g., 60-80 degrees Fahrenheit).

[053] In some implementations, a probiotic deodorant may be maintained at a first temperature range during manufacturing, sale, and/or resale (e.g, refrigerated). In some implementations, a probiotic deodorant may be maintained at a second temperature range by a user. The second temperature range may be different or the same as the first temperature range. In some implementations, the probiotic may be refrigerated prior to sale and stored at room temperature by users. Maintaining the probiotic deodorant at the second temperature range may or may not impact the amount of live probiotic delivered to an area during application of the probiotic deodorant.

[054] The probiotic deodorant may be provided with a date of expiration. Use of the probiotic deodorant after the provided expiration date may deliver less than a

predetermined minimum amount of probiotic to an area of application.

[055] In various implementations, the deodorant may be applied to the skin of a user. For example, the deodorant may be applied to under arms, feet, chest, and/or other external surfaces of the user's body. [056] In some implementations, a user may not be concerned with absorption of the deodorant in the body since the deodorant does not include metallic compounds. Since the deodorant may include probiotics, a user may not be concerned with absorption since probiotics absorption through the skin may not be problematic for humans. In some implementations, since the deodorant includes probiotics and/or is nonmetallic, the safety of the product may be increased (e.g., since ingestion of probiotics may not be harmful and may be beneficial to the user).

[057] Although users have been described as a human, a user may be a person or a group of people.

[058] In various implementations, components have been described as a percentage of an overall composition, unless otherwise indicated the percentages are listed as percentages by weight. In various implementations, when bacteria are described as reduced or a level of bacteria is described as reduced, this may refer to a reduction in the number of bacteria cells.

[059] In various implementations, specific bacteria have been described, other appropriate bacteria that have similar properties may be utilized with the described systems and methods where use does not conflict with the teachings of the disclosure.

[060] In various implementations, pathenogenic bacteria have been described (e.g., the probiotics may overcome pathenogenic bacteria on the external surface of a user and/or the number of pathenogenic bacteria may be reduced). Pathenogenic bacteria may include bacteria that cause infections, diseases and/or ailments in users.

[061] It is to be understood the implementations are not limited to particular systems or processes described which may, of course, vary. It is also to be understood that the terminology used herein is for the purpose of describing particular implementations only, and is not intended to be limiting. As used in this specification, the singular forms "a", "an" and "the" include plural referents unless the content clearly indicates otherwise. Thus, for example, reference to "a substrate" includes a combination of two or more substrates and reference to "a probiotic" includes different types and/or combinations of probiotics.

[062] Although the present disclosure has been described in detail, it should be understood that various changes, substitutions and alterations may be made herein without departing from the spirit and scope of the disclosure as defined by the appended claims. Moreover, the scope of the present application is not intended to be limited to the particular embodiments of the process, machine, manufacture, composition of matter, means, methods and steps described in the specification. As one of ordinary skill in the art will readily appreciate from the disclosure, processes, machines, manufacture, compositions of matter, means, methods, or steps, presently existing or later to be developed that perform substantially the same function or achieve substantially the same result as the corresponding embodiments described herein may be utilized according to the present disclosure. Accordingly, the appended claims are intended to include within their scope such processes, machines, manufacture, compositions of matter, means, methods, or steps.

Claims

1. A deodorant compri sing : a substrate; and one or more probiotics disposed on the substrate, wherein each of the probiotics does not ferment perspiration; wherein a deodorant is applied to an external surface of a human, and wherein a deodorant is nonmetallic.

2. The deodorant of claim 1 wherein at least one of the probiotics is live.

3. The deodorant of claim 1 wherein at least one of he probiotics is dormant.

4. The deodorant of claim 1 wherein each of the probiotics are naturally present in a human.

5. The deodorant of claim 1 wherein application of the deodorant to an external surface of the skin reduces the magnitude of one or more pathenogenic bacteria on the external surface of the skin.

6. The deodorant of claim 1 wherein one or more of the probiotics does not produce one or more predetermined odor causing compounds in a level greater than

approximately 10% of the total compounds produced by the one or more probiotics.

7. The deodorant of claim 1 further comprising one or more additional compounds disposed on the substrate, wherein one of the additional compounds comprises a fragrance.

8. The deodorant of claim 1 wherein the deodorant does not include fat, protein, and carbohydrate.

9. The deodorant of claim 1 wherein the substrate comprises a pad.

10. The deodorant of claim 1 wherein one or more of the probiotics comprises at least one of Lactobacillus or non-pathogenic Streptococci.

11. A deodorant compri sing : a container; one or more probiotics disposed in the container, wherein each of the probiotics does not ferment perspiration; and an applicator, wherein a deodorant is applied to an external surface of a human via the applicator, and wherein a deodorant is nonmetallic wherein during application.

12. The deodorant of claim 11 wherein the applicator comprises a brush.

13. The deodorant of claim 11 wherein at least one of the probiotics is dried, and further comprising a hydrating agent, wherein the hydrating agent is capable of reviving one or more of the probiotics.

14. The deodorant of claim 11 wherein the applicator comprises a rotatable member, and wherein an exterior surface of the rotatable member contacts one or more of the probiotics in the container, and wherein one or more of the probiotics in the container at least temporarily adheres to the rotatable member, and wherein the rotatable member rotates away from a portion of the container in which the one or more probiotics are disposed to allow application of the one or more probiotics adhering to the rotatable member to an external area of a human.

15. A method of applying deodorant comprising: obtaining a substrate with one or more probiotics disposed on the substrate, wherein a hydrating agent has been applied to the substrate to revive one or more of the probiotics, and wherein each of the probiotics does not ferment

perspiration; and applying one or more of the probiotics to an external area of a human by contacting the substrate with the external area.

16. The method of claim 15 further comprising: applying a hydration agent to a substrate of the deodorant to at least partially hydrate the substrate; applying one or more of the probiotics to the substrate from a container in which the one or more probiotics is housed; wherein applying one or more of the probiotics to the at least partially hydrated substrate revives one or more of the probiotics applied to the substrate.

17. The method of claim 15 further comprising: obtaining a substrate with one or more of the probiotics disposed on the substrate; and applying a hydrating agent to the substrate to revive at least a portion of the probiotics disposed on the substrate.

18. The method of claim 15 wherein the substrate comprises an applicator, and wherein obtaining a substrate with one or more probiotics comprises: applying a hydrating agent to the applicator to at least partially hydrate the applicator; and dipping the applicator in a container to allow one or more probiotics to transfer from the container to the applicator, wherein the container houses the one or more probiotics, and wherein at least a portion of the probiotics transferred to the applicator are hydrated by the hydrating agent on the applicator.

19. The method of claim 15 wherein contacting the substrate with the external area exfoliates at least a portion of the skin in the external area.

20. The method of claim 15 wherein the substrate includes a first layer and at least one additional layer, and further comprising removing the first layer of the substrate to allow at least a portion of the probiotics on at least one of the additional layers substrate to be transferred to the external area by contacting the external area with one or more of the additional layers of the substrate.